Sharon Barbari

Insider Reports History

Entity
Individual
Location
280 East Grand Avenue, South San Francisco, CA
Signature
/s/ Geoffrey P. Gilmore, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sharon Barbari:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AGILE THERAPEUTICS INC Director Common Stock 0 $0 $1.52 Aug 26, 2024 Direct
VYNE Therapeutics Inc. Director Stock Option (right to buy) 20K Jan 1, 2024 Direct

Insider Reports Filed by Sharon Barbari

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGRX AGILE THERAPEUTICS INC Aug 26, 2024 1 -$1.48K 4 Aug 26, 2024 Director
VYNE VYNE Therapeutics Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
VYNE VYNE Therapeutics Inc. Dec 13, 2023 1 $0 4 Dec 15, 2023 Director
AGRX AGILE THERAPEUTICS INC Jun 8, 2023 2 $0 4 Jun 9, 2023 Director
VYNE VYNE Therapeutics Inc. Aug 10, 2022 1 $0 4 Aug 12, 2022 Director
AGRX AGILE THERAPEUTICS INC Jun 9, 2022 2 $0 4 Jun 10, 2022 Director
VYNE VYNE Therapeutics Inc. Jul 19, 2021 1 $0 4 Jul 20, 2021 Director
AGRX AGILE THERAPEUTICS INC Jun 8, 2021 2 $0 4 Jun 10, 2021 Director